CHERYL RYDER: Open Payments
NPI 1730179896 · ST PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,418 in 39 payments from 16 companies in 2025. Trend: 2023 $393 · 2024 $848 · 2025 $1,418
Food & beverage: $1,418
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 5 | $210 |
| Eisai Inc. | 5 | $186 |
| PFIZER INC. | 3 | $173 |
| AstraZeneca Pharmaceuticals LP | 7 | $170 |
| Caris MPI, Inc. | 1 | $131 |
| ABBVIE INC. | 3 | $91 |
| GlaxoSmithKline, LLC. | 1 | $86 |
| Baxter Healthcare | 1 | $82 |
| Tempus AI, Inc | 3 | $76 |
| Fennec Pharmaceuticals, Inc. | 2 | $43 |
Products named: Lenvima, KEYTRUDA, MI CANCER SEEK, LYNPARZA, ELAHERE, TISSEEL, XT CDX, TIVDAK.
Industry payments across FL — which companies pay providers there.
